Global Fluralaner API 麻豆原创 Research Report 2025

Publication ID:

PB503258842

Publication Date:

March 20, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Fluralaner API was valued at US$ 80.7 million in the year 2024 and is projected to reach a revised size of US$ 109 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Fluralaner, isoxazoline class compound, is a systemic insecticide and acaricide with antiparasitic activity against cat and dog fleas and ticks. Fluralaner is an inhibitor of the arthropod nervous system. Fluralaner inhibits 纬-aminobutyric acid (GABA)-gated chloride channels (GABACls) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a phenylpyrazole ectoparasiticide). Fluralaner API in this report.
Global key manufacturers of Fluralaner API include Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, etc. Global top five manufacturers hold a share about 85%. Asia-Pacific is the largest market of Fluralaner API, holds a share over 35%. In terms of product, purity above 98% ones hold a larger segment, with a share over 75%. And in terms of application, the largest application is oral drug, with a share of over 70%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fluralaner API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluralaner API.
The Fluralaner API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fluralaner API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluralaner API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Nissan Chemical
Hikal
Hubei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology
Segment by Type
Purity above 98%
Purity below 98%
Segment by Application
Oral Drug
Topical Drug
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fluralaner API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fluralaner API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Fluralaner API 麻豆原创 Overview
1.1 Product Definition
1.2 Fluralaner API by Type
1.2.1 Global Fluralaner API 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Purity above 98%
1.2.3 Purity below 98%
1.3 Fluralaner API by Application
1.3.1 Global Fluralaner API 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Oral Drug
1.3.3 Topical Drug
1.4 Global Fluralaner API 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Fluralaner API Revenue 2020-2031
1.4.2 Global Fluralaner API Sales 2020-2031
1.4.3 Global Fluralaner API 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Fluralaner API 麻豆原创 Competition by Manufacturers
2.1 Global Fluralaner API Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Fluralaner API Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Fluralaner API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Fluralaner API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fluralaner API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fluralaner API, Product Type & Application
2.7 Global Key Manufacturers of Fluralaner API, Date of Enter into This Industry
2.8 Global Fluralaner API 麻豆原创 Competitive Situation and Trends
2.8.1 Global Fluralaner API 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Fluralaner API Players 麻豆原创 Share by Revenue
2.8.3 Global Fluralaner API 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fluralaner API 麻豆原创 Scenario by Region
3.1 Global Fluralaner API 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Fluralaner API Sales by Region: 2020-2031
3.2.1 Global Fluralaner API Sales by Region: 2020-2025
3.2.2 Global Fluralaner API Sales by Region: 2026-2031
3.3 Global Fluralaner API Revenue by Region: 2020-2031
3.3.1 Global Fluralaner API Revenue by Region: 2020-2025
3.3.2 Global Fluralaner API Revenue by Region: 2026-2031
3.4 North America Fluralaner API 麻豆原创 Facts & Figures by Country
3.4.1 North America Fluralaner API 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Fluralaner API Sales by Country (2020-2031)
3.4.3 North America Fluralaner API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fluralaner API 麻豆原创 Facts & Figures by Country
3.5.1 Europe Fluralaner API 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Fluralaner API Sales by Country (2020-2031)
3.5.3 Europe Fluralaner API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fluralaner API 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Fluralaner API 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Fluralaner API Sales by Region (2020-2031)
3.6.3 Asia Pacific Fluralaner API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fluralaner API 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Fluralaner API 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Fluralaner API Sales by Country (2020-2031)
3.7.3 Latin America Fluralaner API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fluralaner API 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Fluralaner API 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Fluralaner API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Fluralaner API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fluralaner API Sales by Type (2020-2031)
4.1.1 Global Fluralaner API Sales by Type (2020-2025)
4.1.2 Global Fluralaner API Sales by Type (2026-2031)
4.1.3 Global Fluralaner API Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Fluralaner API Revenue by Type (2020-2031)
4.2.1 Global Fluralaner API Revenue by Type (2020-2025)
4.2.2 Global Fluralaner API Revenue by Type (2026-2031)
4.2.3 Global Fluralaner API Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Fluralaner API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Fluralaner API Sales by Application (2020-2031)
5.1.1 Global Fluralaner API Sales by Application (2020-2025)
5.1.2 Global Fluralaner API Sales by Application (2026-2031)
5.1.3 Global Fluralaner API Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Fluralaner API Revenue by Application (2020-2031)
5.2.1 Global Fluralaner API Revenue by Application (2020-2025)
5.2.2 Global Fluralaner API Revenue by Application (2026-2031)
5.2.3 Global Fluralaner API Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Fluralaner API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Nissan Chemical
6.1.1 Nissan Chemical Company Information
6.1.2 Nissan Chemical Description and Business Overview
6.1.3 Nissan Chemical Fluralaner API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Nissan Chemical Fluralaner API Product Portfolio
6.1.5 Nissan Chemical Recent Developments/Updates
6.2 Hikal
6.2.1 Hikal Company Information
6.2.2 Hikal Description and Business Overview
6.2.3 Hikal Fluralaner API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Hikal Fluralaner API Product Portfolio
6.2.5 Hikal Recent Developments/Updates
6.3 Hubei Masteam Bio-tech
6.3.1 Hubei Masteam Bio-tech Company Information
6.3.2 Hubei Masteam Bio-tech Description and Business Overview
6.3.3 Hubei Masteam Bio-tech Fluralaner API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hubei Masteam Bio-tech Fluralaner API Product Portfolio
6.3.5 Hubei Masteam Bio-tech Recent Developments/Updates
6.4 Jiangsu Rivocean
6.4.1 Jiangsu Rivocean Company Information
6.4.2 Jiangsu Rivocean Description and Business Overview
6.4.3 Jiangsu Rivocean Fluralaner API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangsu Rivocean Fluralaner API Product Portfolio
6.4.5 Jiangsu Rivocean Recent Developments/Updates
6.5 Shaanxi Dideu
6.5.1 Shaanxi Dideu Company Information
6.5.2 Shaanxi Dideu Description and Business Overview
6.5.3 Shaanxi Dideu Fluralaner API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shaanxi Dideu Fluralaner API Product Portfolio
6.5.5 Shaanxi Dideu Recent Developments/Updates
6.6 Zhejiang Gihi Chemicals
6.6.1 Zhejiang Gihi Chemicals Company Information
6.6.2 Zhejiang Gihi Chemicals Description and Business Overview
6.6.3 Zhejiang Gihi Chemicals Fluralaner API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhejiang Gihi Chemicals Fluralaner API Product Portfolio
6.6.5 Zhejiang Gihi Chemicals Recent Developments/Updates
6.7 Hunan Huateng Pharmaceutical
6.7.1 Hunan Huateng Pharmaceutical Company Information
6.7.2 Hunan Huateng Pharmaceutical Description and Business Overview
6.7.3 Hunan Huateng Pharmaceutical Fluralaner API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hunan Huateng Pharmaceutical Fluralaner API Product Portfolio
6.7.5 Hunan Huateng Pharmaceutical Recent Developments/Updates
6.8 Taizhou Crene Biotechnology
6.8.1 Taizhou Crene Biotechnology Company Information
6.8.2 Taizhou Crene Biotechnology Description and Business Overview
6.8.3 Taizhou Crene Biotechnology Fluralaner API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Taizhou Crene Biotechnology Fluralaner API Product Portfolio
6.8.5 Taizhou Crene Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fluralaner API Industry Chain Analysis
7.2 Fluralaner API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fluralaner API Production Mode & Process Analysis
7.4 Fluralaner API Sales and 麻豆原创ing
7.4.1 Fluralaner API Sales Channels
7.4.2 Fluralaner API Distributors
7.5 Fluralaner API Customer Analysis
8 Fluralaner API 麻豆原创 Dynamics
8.1 Fluralaner API Industry Trends
8.2 Fluralaner API 麻豆原创 Drivers
8.3 Fluralaner API 麻豆原创 Challenges
8.4 Fluralaner API 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Nissan Chemical
Hikal
Hubei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.